DE60134885D1 - Antiangiogene polypeptide - Google Patents

Antiangiogene polypeptide

Info

Publication number
DE60134885D1
DE60134885D1 DE60134885T DE60134885T DE60134885D1 DE 60134885 D1 DE60134885 D1 DE 60134885D1 DE 60134885 T DE60134885 T DE 60134885T DE 60134885 T DE60134885 T DE 60134885T DE 60134885 D1 DE60134885 D1 DE 60134885D1
Authority
DE
Germany
Prior art keywords
antiangiogenic polypeptide
antiangiogenic
polypeptide
disclosed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60134885T
Other languages
English (en)
Inventor
David M Waisman
Geetha Kassam
Mijung Kwon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60134885D1 publication Critical patent/DE60134885D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DE60134885T 2000-11-28 2001-11-28 Antiangiogene polypeptide Expired - Fee Related DE60134885D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25372500P 2000-11-28 2000-11-28
PCT/US2001/044515 WO2002044328A2 (en) 2000-11-28 2001-11-28 Anti-angiogenic polypeptides

Publications (1)

Publication Number Publication Date
DE60134885D1 true DE60134885D1 (de) 2008-08-28

Family

ID=22961462

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134885T Expired - Fee Related DE60134885D1 (de) 2000-11-28 2001-11-28 Antiangiogene polypeptide

Country Status (8)

Country Link
US (2) US7420036B2 (de)
EP (1) EP1337548B1 (de)
CN (1) CN100491394C (de)
AT (1) ATE401337T1 (de)
AU (1) AU2002239366A1 (de)
CA (1) CA2426543C (de)
DE (1) DE60134885D1 (de)
WO (1) WO2002044328A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60134885D1 (de) 2000-11-28 2008-08-28 David M Waisman Antiangiogene polypeptide
AU2002357017A1 (en) 2001-11-28 2003-06-10 Mediomics, Llc Anti-angiogenesis methods, compositions and uses therefor
EP1501861A4 (de) * 2002-05-06 2007-06-20 Univ Texas Gezielt bindende proteine zur verabreichung therapeutischer oder diagnostischer reagentien
AU2003297181A1 (en) 2002-12-13 2004-07-09 Mediomics, Llc Compositions and methods for inhibiting tumor growth and metastasis
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors
CN101219219B (zh) * 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
EP0467987A4 (en) 1989-05-01 1992-07-08 The University Of Notre Dame Du Lac Methods and materials for expression of human plasminogen in a eukaryotic cell system
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5945403A (en) 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
IL126626A0 (en) 1996-05-03 1999-08-17 Abbott Lab Novel antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
WO1999000420A1 (en) 1997-06-26 1999-01-07 Karolinska Innovations Ab Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
ID27676A (id) * 1997-09-11 2001-04-19 Sony Corp Peralatan elektronik
JP2001518304A (ja) 1997-10-01 2001-10-16 ジー・ディー・サール・アンド・カンパニー アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用
ATE346607T1 (de) 2000-09-01 2006-12-15 Philadelphia Health & Educatio Verfahren und zusammensetzungen zur inhibition der angiogenese
DE60134885D1 (de) 2000-11-28 2008-08-28 David M Waisman Antiangiogene polypeptide

Also Published As

Publication number Publication date
WO2002044328A3 (en) 2003-04-03
US7420036B2 (en) 2008-09-02
CA2426543A1 (en) 2002-06-06
ATE401337T1 (de) 2008-08-15
WO2002044328A2 (en) 2002-06-06
EP1337548A2 (de) 2003-08-27
US7626008B2 (en) 2009-12-01
CN100491394C (zh) 2009-05-27
US20090061510A1 (en) 2009-03-05
EP1337548B1 (de) 2008-07-16
AU2002239366A1 (en) 2002-06-11
US20040082030A1 (en) 2004-04-29
CA2426543C (en) 2007-09-18
EP1337548A4 (de) 2005-01-12
CN1498223A (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
NO20034056D0 (no) Proliferative sykdommer
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
CO5611160A2 (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
DE60143061D1 (de) Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
MXPA03010085A (es) Composiciones y su uso en la hiperplasia.
ATE275583T1 (de) KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
DK1503788T3 (da) Behandling af alpha-galactosidase A-deficiens
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
BR0107691A (pt) Sapogeninas substituìdas e seu uso
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DK1441761T3 (da) Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr
ATE401337T1 (de) Antiangiogene polypeptide
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DE60217539D1 (de) Leichtathletikschuh
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
TR200200278T2 (tr) Kalsilitik bileşimler
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
WO2001051511A3 (de) Rekombinante herstellung von humanen histon 1-subtypen sowie deren verwendung für therapeutische zwecke
DK1303294T3 (da) Fremgangsmåde til behandling af instabil angina pectoris
TR200002939T2 (tr) Paroksetin maleat
SI1276495T1 (sl) Uporaba rekombinantnega pljucnega surfaktanta za zgodnje zdravljenje akutnih pljucnih bolezni
NO20005548L (no) Mykobakterieinhibitorer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee